E
Vyant Bio, Inc. VYNT
OTC PK
Recommendation
Sell
Prev Close
$0.194
Volume
--
Avg Vol (90D)
3,320
Market Cap
--
Dividend & Yield
--
52-Week Range
$0.141 - $0.60
P/E (TTM)
--
EPS (TTM)
-$2.28
My Lists My Alerts
Report
Rating
Reward
E
Very Weak
Risk
E+
Very Weak
Rating Factors
Growth Index
Fair
Efficiency Index
Very Weak
Solvency Index
Good
Total Return Index
Very Weak
Volatility Index
Very Weak
Dividend Index
--
Headlines
Critical Analysis: Vyant Bio (NASDAQ:VYNT) & Aclarion (NASDAQ:ACON)
5/20/2023 - Ticker Report
Vyant Bio to pursue listing on OTC Pink Open Market
5/12/2023 - Proactive Investors - UK
Vyant Bio Announces Last Day of Trading on Nasdaq and Filing of Form 15 for Voluntary Nasdaq Delisting and SEC Deregistration
5/12/2023 - Globe Newswire
Vyant Bio, Inc. (NASDAQ:VYNT) Short Interest Update
5/12/2023 - Ticker Report
Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
5/11/2023 - InvestorPlace
Income Statement
Total Revenue (TTM)
$397.00K
EBITDA (TTM)
-$13.28M
EBIT (TTM)
-$13.68M
Net Income (TTM)
-$13.83M
Balance Sheet
Total Assets (Q)
$6.23M
Total Debt (Q)
$708.00K
Total Liabilities (Q)
$1.73M
Book Value Per Share (Q)
$0.7112
Cash Flow
Cash from Operations (TTM)
-$12.96M
Cash from Investing (TTM)
$3.75M
Cash from Financing (TTM)
$305.00K
Net Change in Cash (TTM)
-$8.91M
Filings
Filing Date
Wednesday, August 16, 2023
Period Date
Friday, June 30, 2023
Next Filing
(est)
Price History
Loading...
Beta
1.22
7-Day Total Return
0.00%
30-Day Total Return
0.00%
60-Day Total Return
0.00%
90-Day Total Return
12.46%
Year to Date Total Return
0.00%
1-Year Total Return
-34.88%
2-Year Total Return
-94.96%
3-Year Total Return
-98.81%
5-Year Total Return
--
52-week Low
Sep 20, 2023 - $0.141
52-week High
May 10, 2023 - $0.60
Valuation
Market Cap
-- - --
Enterprise Value
--
Price/Sales (TTM)
3.09
Price/Book (Q)
0.27
Dividends and Shares
Shares Outstanding
6.33M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.vyantbio.com
Phone Number
201 479 1357
Address
2 Executive Campus
2370 State Route 70 - Suite 310
Cherry Hill, NJ 08002
Country
United States
Year Founded
--
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Vyant Bio, Inc., a biotechnology company, discovers drugs for complex neurodevelopmental and neurodegenerative disorders. The company’s central nervous system (CNS) drug discovery platform... more
Weiss Ratings